Managed by MedSciCommsNet (MSCN)

MedComms Networking is a not-for-profit initiative building on the work of Peter Llewellyn which seeks to unite individuals and organisations involved in delivering health information

MedComms Networking is a not-for-profit initiative building on the work of Peter Llewellyn which seeks to unite individuals and organisations involved in delivering health information. We will do this by listening and by delivering a weekly newsletter and regular online and in-person events. Our group welcomes writers, scientists, editors, educators, project managers, filmmakers, medical journalists, healthcare professionals, researchers, academics, and patient advocates from around the world to join us. The aim is to inform, educate and advance our profession and, ultimately, support patient care.

Please sign up to receive our Newsletter and information about future events.

MORE DETAILS

  • Home
  • About us
  • Events
  • In the News
  • Companies
  • Independents
  • Services
  • Job Adverts
  • Webcasts
  • Starting out
  • Survey data
  • Supporters

  • Join the conversation on LinkedIn. Use hashtag #MedComms


    MedComms Networking is supported by:

    Many thanks to the Supporters of MedComms Networking

    AFTERNOON WORKSHOP - 7 JULY 2016 - ALDERLEY PARK

    Understanding the role of real-world evidence (RWE) in a medical publication plan

    This was another successful workshop hosted by AstraZeneca and attracted a full house once again, for a valuable afternoon's programme chaired by John Gonzalez of AstraZeneca and Ryan Woodrow of Aspire Scientific. As usual the meeting not only served as a valuable educational opportunity but allowed plenty of time for networking with colleagues from across the MedComms business.

    Date: 7 July 2016

    Venue: Alderley Park Conference Centre, Macclesfield, Cheshire, SK104TG

    ISMPP

    PROGRAMME:

    13.00 Registration and lunch

    14.00 Welcome - Ryan Woodrow of Aspire Scientific

    14.05 Chair's Introduction - John Gonzalez of AstraZeneca

    14.10 * Fundamentals of RWE, and how evidence is gathered - Andy Shaw of AstraZeneca

    [DOWNLOAD PRESENTATION - PDF]

    14.40 * What are the specific issues for RWE study publications? - Stephen Sweet and Gary Male of Oxford PharmaGenesis

    [DOWNLOAD PRESENTATION - PDF]

    15.10 Coffee

    15.45 * How should an RWE study plan be developed and communicated? - Tim Koder of Oxford PharmaGenesis

    [DOWNLOAD PRESENTATION - PDF]

    16.15 Panel discussion and Q&A with Mariam Bibi of Double Helix Consulting, Steve Fermer of Adelphi Real World, Tim Koder of Oxford PharmaGenesis and Andy Shaw of AstraZeneca

    16.45 Chair's round-up - John Gonzalez of AstraZeneca

    16.55 Meeting close - Ryan Woodrow of Aspire Scientific

    NetworkPharma

    To make sure you're included in announcements about future events just email Peter Llewellyn, if you haven't already done so, to register your interest.

    WHAT ELSE?

    This meeting was free to attend thanks to the generosity of the event sponsors, AstraZeneca

    AstraZeneca


    This web site is managed on a not-for-profit basis by MedSciCommsNet (MSCN) Ltd | Contact email steven_tim@medscn.org